The Lodge of the Morning Star No.5428

Supporting Charities 2019-2020

Worshipful Master Stephen Smith's year which concluded in November raised £3,203.70
for three charities including his and Andrea's personal charity, Pancreatic Cancer UK which has
benefitted by £2,400.00.

The cheque to Pancreatic Cancer UK  was formally presented on 16th December 2019.

Other beneficiaries from our fundraising included the Sikh Soldiers' Memorial which was unveiled on 30th November 2019 and commemorates over 83,000 Sikh's who died in both World Wars. The statur was cast in Mumbai and the plinth is Yorshire stone. It is situated in Greenhead Park, Huddersfield.

sikh soldiers memorial.jpg 

Supporting Pancreatic Cancer UK

Pancreatic Presentation.jpg

Pancreatic cancer is the 11th most common cancer. This represents around 3% of cancer cases in the UK.

 8 people every day receive a pancreatic cancer diagnosis.

The age standardised incidence rate is 16.1 per 100,000 population.  Incidence is slightly increasing over the years but not significantly

Pancreatic cancer is the fifth biggest cancer killer

 9,000 people die every year from pancreatic cancer in the UK.

 One person dies of pancreatic cancer every hour.

 Pancreatic cancer is predicted to be the fourth leading cancer death by 2026 in the UK. 

 This is because there is more progress in other cancers but not for pancreatic cancer. It is not because incidence or mortality are significantly increasing.

 Pancreatic cancer is tough to diagnose:

 Pancreatic cancer is difficult to diagnose at an early stage

 Late diagnosis can be because of vague and non-specific symptoms, lack of screening tools and biomarkers and lack of symptom awareness in primary care and the public.

We need more innovative pathway developments for earlier and faster diagnosis. Innovative examples are the rapid access jaundice pathway and the Rapid Diagnostic Centres (RDC) for vague and non-specific symptoms.

 Pancreatic cancer is tough to treat

 Treatment options for pancreatic cancer are limited.

7 in 10 patients will not receive any active treatment (surgery or chemotherapy).

 Surgery is the only potentially curative treatment; however, only 1 in 10 people will receive surgery. 

 Tough to research  

 Pancreatic cancer research has historically been underfunded.

 The disease attracts just 2.3% of the NCRI annual cancer research budget that is £14,657,348 (2017/2018).

 Only 12% of pancreatic cancer research is spent on early diagnosis, detection and prognosis research (2016-2017).

 This represents half the investment in early diagnosis and detection compared to average across all cancers – with 22% invested in early diagnosis across all cancers sites, in 2016/2017.

 To see real breakthroughs in pancreatic cancer outcomes, the UK-wide funding needs to increase to £25m per year.


Pancreatic Cancer UK

6th Floor Westminster Tower     

3 Albert Embankment London SE1 7SP

 Direct line: 020 3818 8946             Main number: 0203 535 7090

Pancreatic Cancer UK Support Line: Freephone 0808 801 0707